UK markets closed

DarioHealth Corp. (DRIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.7600+0.1600 (+10.00%)
At close: 04:00PM EDT
1.7600 +0.01 (+0.57%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 52.66M
Enterprise value 48.73M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.78
Price/book (mrq)0.67
Enterprise value/revenue 2.56
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.65
52-week change 3-54.17%
S&P500 52-week change 326.14%
52-week high 34.5800
52-week low 30.6800
50-day moving average 31.4968
200-day moving average 31.9863

Share statistics

Avg vol (3-month) 3140.19k
Avg vol (10-day) 3235.97k
Shares outstanding 529.92M
Implied shares outstanding 632.54M
Float 824.07M
% held by insiders 114.70%
% held by institutions 130.17%
Shares short (30 Apr 2024) 41.35M
Short ratio (30 Apr 2024) 410.24
Short % of float (30 Apr 2024) 45.08%
Short % of shares outstanding (30 Apr 2024) 44.54%
Shares short (prior month 28 Mar 2024) 41.36M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Nov 2019
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin -292.00%
Operating margin (ttm)-389.57%

Management effectiveness

Return on assets (ttm)-32.51%
Return on equity (ttm)-86.04%

Income statement

Revenue (ttm)20.35M
Revenue per share (ttm)0.72
Quarterly revenue growth (yoy)-46.90%
Gross profit (ttm)N/A
EBITDA -51.08M
Net income avi to common (ttm)-54.86M
Diluted EPS (ttm)-1.9300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)36.8M
Total cash per share (mrq)1.25
Total debt (mrq)29.54M
Total debt/equity (mrq)50.81%
Current ratio (mrq)3.79
Book value per share (mrq)2.14

Cash flow statement

Operating cash flow (ttm)-30.38M
Levered free cash flow (ttm)-7.44M